MPP supports technology transfer in LMICs to progress our manufacturing partners work towards commercially viable products. The success of a product’s development and commercial manufacturing heavily relies on effective management of technology transfer. MPP can support these complex processes by leveraging its internal expertise to ensure their seamless execution.
Technology Transfer experts from MPP provide expertise in Drug Substance (DS) and Drug Product (DP) development and technology transfer across various product types (including small molecules and biologics) and finished forms. Competencies span from infrastructure & equipment design, process & analytical development, process optimization, scale-up, validation, preclinical evaluation, regulatory compliance, commercial launch and overall project management, ensuring seamless integration into our partners operations.
Tailored support is provided according to the project and our partner needs, ensuring that the product meets the highest quality standards and regulatory requirements. The goal is to ensure a smooth and efficient technology transfer, minimizing risks and accelerating product commercialisation.
MPP provides technology transfer support
How does MPP support tech transfer?
Customized type and level of support evaluated on a case-by-case basis, to meet specific project needs.
Why MPP tech transfer support?
Alleviate resource-intensity for both sending unit (SU) and receiving units (RU), especially in LMICs settings where non-technical and technical challenges are often amplified.
Additional support to SU and/or RUs seeking complementary skills and expertise in the realm of the tech transfer activities.
Why tech transfer?
For LMICs, biological products and complex formulations technology transfer is imperative to enable local manufacturing.
What MPP tech transfer brings?
Technical support (remote and onsite) bridging the gaps between the SU and RUs, enabling recipients to absorb the technology and produce quality-assured products.
